Tormod Fladby - Neurology

Author Information

Tormod Fladby is a renowned researcher affiliated with the Department of Neurology at Akershus University Hospital in Lørenskog, Norway. His work primarily focuses on neurology, with a particular interest in Alzheimer's disease and cognitive decline.

Research Contributions

Tormod Fladby has made significant contributions to the understanding of cognitive decline and Alzheimer's disease. His recent research, such as the study on the association of Timed Up and Go with cognitive deterioration and the exploration of genetic etiologies in Alzheimer's disease, highlights his focus on identifying biomarkers and understanding the genetic factors influencing neurological conditions. His work on amyloid abnormalities and their prevalence across the Alzheimer's disease spectrum further underscores his commitment to advancing knowledge in this critical area of neurology.

Aliases

Tormod Fladby is also known by several aliases, including T. Fladby and T Fladby. These variations of his name are used across different publications and academic contributions.

Publication and Citation Metrics

Metric	Value
Total Papers	199
Total Citations	9296
H-index	41

Publications:

Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness

DOI: 10.1159/000522094

Year: 2022

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

DOI: 10.1001/jamaneurol.2021.5216

Year: 2022

New insights into the genetic etiology of Alzheimer's disease and related dementias.

DOI: 10.1038/s41588-022-01024-z

Year: 2022

The Relationship of Psychiatric Symptoms with Performance-Based and Self-Reported Cognitive Function After Ischemic Stroke

DOI: 10.1017/S1355617721000187

Year: 2021

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

DOI: 10.1038/s41398-021-01213-0

Year: 2021

Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

DOI: 10.1038/s41588-021-00977-x

Year: 2021

Diagnostic accuracy of the monocyte Aβ mid‐domain assay for CSF determined brain amyloid deposition

DOI: 10.1002/alz.056435

Year: 2021

Regulation of intracellular innate immune amyloid beta (aβ) clearance

DOI: 10.1002/alz.056329

Year: 2021

A new blood‐based biomarker of Aβ clearance: The monocyte Aβ mid‐domain assay

DOI: 10.1002/alz.056346

Year: 2021

Characteristics of subjective cognitive decline associated with amyloid positivity.

DOI: 10.1002/alz.12512

Year: 2021

What Technologies Aid Customizable Neurocare?

How Do Dopaminergic Drugs Work?

What is the role of insulin resistance?

How is Chronic Pain Related to Neurology?

What Conditions Can EEG Diagnose?

What is Personalized Medicine?

What is the Role of Technology in Neurocare?

What is the Mediterranean Diet?

What Causes Spasticity?

What Diagnostic Tools Are Used in Neurology?

Partnered Content Networks

Relevant Topics